(R,S)2-[4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl]-4-hydroxybutanamide

ID: ALA1651898

PubChem CID: 51031488

Max Phase: Preclinical

Molecular Formula: C21H25F2N3O2

Molecular Weight: 389.45

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)C(CCO)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1

Standard InChI:  InChI=1S/C21H25F2N3O2/c22-17-5-1-15(2-6-17)20(16-3-7-18(23)8-4-16)26-12-10-25(11-13-26)19(9-14-27)21(24)28/h1-8,19-20,27H,9-14H2,(H2,24,28)

Standard InChI Key:  BFBWMDDWOUKCDH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   21.8841   -2.3122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4721   -1.6015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6483   -1.6015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2364   -2.3122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4721   -3.0270    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.7121   -2.3122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6483   -3.0270    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.8841   -0.8866    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4721   -0.1717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8841    0.5390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7121    0.5390    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.1240   -0.1717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7121   -0.8866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1240    1.2539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7121    1.9646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8841    1.9646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4721    2.6795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8841    3.3944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7121    3.3944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1240    2.6795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4721    4.1127    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   23.9479    1.2539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3598    1.9646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1837    1.9646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5956    1.2539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1837    0.5390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3598    0.5390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4194    1.2539    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  0
  3  4  1  0
  1  5  2  0
  1  6  1  0
  4  7  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  8 13  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 15 20  2  0
 18 21  1  0
 14 15  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 22 27  2  0
 25 28  1  0
 14 22  1  0
 11 14  1  0
  2  8  1  0
M  END

Associated Targets(Human)

SLC6A11 Tchem GABA transporter 3 (176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A13 Tchem GABA transporter 2 (120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A1 Tclin GABA transporter 1 (308 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Slc6a1 GABA transporter 1 (1980 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 389.45Molecular Weight (Monoisotopic): 389.1915AlogP: 1.91#Rotatable Bonds: 7
Polar Surface Area: 69.80Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.43CX LogP: 2.08CX LogD: 2.04
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.76Np Likeness Score: -0.69

References

1. Kulig K, Więckowski K, Więckowska A, Gajda J, Pochwat B, Höfner GC, Wanner KT, Malawska B..  (2011)  Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors.,  46  (1): [PMID:21111516] [10.1016/j.ejmech.2010.11.001]

Source